BioSpace News Archive

Melanoma skin cancer is considered the deadliest form of the disease. Melanoma skin cancer is caused by the formation of faulty DNA caused by UV radiation from tanning beds or sunshine.

Transparency Market Research has published a new report titled, ‘Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Transparency Market Research has published a new report titled, ‘Medical Image Analysis Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global disposable syringes market was valued at US$ 6.9 Bn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period from 2020 to 2030.

RELIEF THERAPEUTICS Holding SA reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals, Inc., has issued a press release announcing they have submitted a revised Investigational New Drug module on the manufacturing of ZYESAMI to the U.S. Food and Drug Administration, containing documentation that confirmed Nephron Pharmaceuticals, Inc. is prepared to supply ZYESAMI on a commercial scale.

International medical imaging IT and cybersecurity company Sectra will deliver the radiology module of its enterprise imaging solution to the University Hospital Basel in Switzerland.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021.

Biogen Inc. announced new data from its industry-leading portfolio of multiple sclerosis therapies.

The SynGAP Research Fund announces grants to Drs. April Levin, Mustafa Sahin and Annapurna Poduri of Boston Children’s Hospital to advance SYNGAP1 biomarker characterization and genotype-phenotype analysis.

ReForm Biologics Inc. today announced that Robert Mahoney, PhD, has been promoted to Chief Scientific Officer (CSO) and that Kevin Kavanaugh, CPA, has been promoted to Chief Financial Officer.